adm glp-1 User Support Products GLP-1 users taking more share
Description
The association was consistent across alcohol- and non-alcohol-related overdoses and was even stronger among patients not receiving traditional addiction-treatment medications
Sources for Figure 218
Supports healthy appetite regulation and metabolic function*
Effectiveness and Impact Significant Weight Loss: Phase 2 studies showed up to roughly 20% average body weight loss at 52 weeks in participants with obesity
Methods This systematic review was conducted across PubMed/MEDLINE and Web of Science
